Stock CARA CARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cara Therapeutics, Inc.

Equities

CARA

US1407551092

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
0.7331 USD -7.46% Intraday chart for Cara Therapeutics, Inc. -3.36% -1.33%
Mar. 22 Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024 CI
Mar. 06 Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CARA THERAPEUTICS, INC. Stock Cara Therapeutics, Inc.
 43.31M -
CSL LIMITED Stock CSL Limited
 89.33B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 41.19B
BIOGEN INC. Stock Biogen Inc.
 31.87B
UCB Stock UCB
 24.52B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.68B
  1. Stock Market
  2. Equities
  3. CARA Stock
  4. Charts Cara Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW